As the CLARITY Act advances, crypto’s growing political influence in Washington is under scrutiny. But the crypto lobby’s massive campaign spend is only part of the story.

FeaturesRead More

You might also be interested in reading Summit Therapeutics Non-GAAP EPS of -$0.12 misses by $0.02.